Featured Article
ZYTIGA™ (Abiraterone Acetate) Receives FDA Approval For Treatment Of Metastatic Prostate Cancer After Priority Review
Horsham, PA (April 28, 2011) – Centocor Ortho Biotech Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ZYTIGA™ (abiraterone acetate), an oral, once-daily medication for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel.
Androgens are hormones that promote the development and maintenance of male sex characteristics. However, in prostate cancer, androgens can help fuel the tumor’s growth. Androgen production primarily occurs in the testes and adrenal glands; in men with prostate cancer, the tumor tissue is an additional source of androgens. ZYTIGA is an oral androgen biosynthesis inhibitor that works by inhibiting the CYP17 enzyme complex, which is required for the production of androgens at these three sources. 
Obama Administration Fights to Save Healthcare Law
Lawyers for President Barack Obama go to court Tuesday to try to save the cornerstone of his healthcare overhaul, arguing that the requirement for Americans to buy insurance is constitutional.
US attacks on New Zealand drug agency draw anger
The US Trade Representative's latest Special 301 report's criticisms of New Zealand's drug agency PHARMAC have drawn angry responses in that country.
Innovative Bed Bug Trap by SpringStar Inc. Catches Hundreds of Bed Bugs at Local Shelter
With the ban on DDT and other powerful pesticides, bed bugs are back with a vengeance and spreading across the country. From hotels to homes and businesses, they are piggybacking on traveler’s bags, clothes and other personal belongings and end up in the strangest places: libraries; hospitals; department store changing rooms; and even movie theaters. 
Harvard Medical School Faculty Advances Drug Safety Research with IBM Business Analytics
IBM (NYSE: IBM) announced that faculty from Harvard Medical School and Brigham & Women's Hospital will use IBM business analytics technology at the core of new research that examines the effectiveness of prescription drugs and spots potential safety issues.
Argentina assures India on sorting out import restrictions on Indian pharma products
Argentina has assured India that it would solve the issues pertaining to restrictions on Indian pharma firms for exporting formulations and said that it would buy drugs worth 150-200 million US dollars from India in the interim.
Cipla introduces new pain free screening technology for early detection of breast cancer in India
Cipla, one of the leading pharmaceutical companies from India, announces the launch of a breakthrough screening technology in India today called the ‘No Touch Breast Scan (NTBS); ' the first-ever painless, non-invasive and radiation-free breast scanning technique for detecting breast cancer at an early stage.
Sri Lanka blacklists Indian drug suppliers
Sri Lanka's Ministry of Health has blacklisted at least a dozen of Indian drug suppliers for violating tendering procedures and supplying low quality medicines.
Jawaharlal Nehru Pharma City to see investment of Rs.25000 crore by 2017
The Jawaharlal Nehru Pharma City (JNPC) in Visakhapatnam, a joint venture between the Hyderabad-based Ramky Group and Andhra Pradesh Industrial Infrastructure Corporation (APIIC), is expected to see a total investment of Rs.25000 crore by 2017
Hiding bin Laden: Finger of suspicion at ISI
The finger of suspicion is now pointing squarely at the Pakistani military and intelligence for sheltering and protecting Osama bin Laden before US forces hunted him down and put a bullet in his head in the wee hours of Sunday. The coordinates of the action and sequence of events indicate that the al-Qaida fugitive may have been killed in an ISI safehouse.
Japan Nuclear Plant Shutdown Adds New Risk to Economy Auto Industry
The surprise closure of another Japanese nuclear plant, this time at the power supplier to the heart of the auto industry, threatens to dampen consumer sentiment and will provide car makers with yet another reason to produce fewer cars in Japan.
Topman Announces Exclusive Sunglasses for Rock You Shades Day Topman is proud to announce it is producing four exclusive designs of sunglasses to help raise much needed funds and increase awareness for the Teenage Cancer Trust and the charity's Rock Your Shades day on Friday 6th May.
Microsoft buys Skype for $8.5bn US software giant Microsoft will buy Internet phone service company Skype for $8.5 billion dollars, Skype is a phenomenal service that is loved by millions of people around the world," Microsoft chief executive Steve Ballmer said
| 
No comments:
Post a Comment